Multiple Sclerosis (MS) Drugs
Additional Reading
- Interferons in relapsing remitting multiple sclerosis: a systematic review
- Growth dynamics of meningiomas in patients with multiple sclerosis
- Multiple sclerosis, interferon beta and clinical thyroid dysfunction
- Arthritis during interferon beta-1b treatment in multiple sclerosis
- Risk-benefit assessment of glatiramer acetate (Copaxone) in multiple sclerosis
- Comparison of glatiramer acetate (Copaxone) and interferon beta-1b (Betaferon) in multiple sclerosis patients